Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 18 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2026 Filed Sep 16, 2026 01:12 UTC |
Duprey Lauren RusckowskiChief Transformation Officer
|
SaleAmerican Depositary Shares | 34,535 | $18.54 | $640,278.90 |
DisclosureSEC source: 0001395064-26-000340 · wk-form4_1789521164.xml · nonDerivative · entry 1 Duprey Lauren Rusckowski · CIK 0001977746 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,522 Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 01:49 UTC |
Plump Andrew StewartDirector · President, R&D
|
SaleAmerican Depositary Shares | 116,191 | $18.49 | $2,148,371.59 |
DisclosureSEC source: 0001395064-26-000335 · wk-form4_1788486556.xml · nonDerivative · entry 1 Plump Andrew Stewart · CIK 0001977689 · Director · President, R&D 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 145,465 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:30 UTC |
Plump Andrew StewartDirector · President, R&D
|
SaleAmerican Depositary Shares | 19,651 | $18.49 | $363,346.99 |
DisclosureSEC source: 0001493152-26-039693 · ownership.xml · nonDerivative · entry 1 Plump Andrew Stewart · CIK 0001977689 · Director · President, R&D 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 261,656 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026. Read SEC document |
| August 18, 2026 Filed Aug 19, 2026 20:15 UTC |
Greenway Nicola Deidre PetalChief Human Resources Officer
|
SaleAmerican Depositary Shares | 12,980 | $18.11 | $235,118.42 |
DisclosureSEC source: 0001493152-26-039214 · ownership.xml · nonDerivative · entry 1 Greenway Nicola Deidre Petal · CIK 0002123546 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,049 Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 20:10 UTC |
Shannon Elaine MaryPres., Global Supply & Quality
|
SaleAmerican Depositary Shares | 20,363 | $17.55 | $357,370.65 |
DisclosureSEC source: 0001493152-26-037352 · ownership.xml · nonDerivative · entry 1 Shannon Elaine Mary · CIK 0002009368 · Pres., Global Supply & Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,311 Read SEC document |
| August 10, 2026 Filed Aug 13, 2026 01:42 UTC |
Shannon Elaine MaryPres., Global Supply & Quality
|
SaleAmerican Depositary Shares | 3,978 | $17.10 | $68,023.80 |
DisclosureSEC source: 0001493152-26-037499 · ownership.xml · nonDerivative · entry 1 Shannon Elaine Mary · CIK 0002009368 · Pres., Global Supply & Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,333 F1 · kind: Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: The total in Column 5 represents the amount of American Depositary Shares held by the Reporting Person as of the date of this filing. Read SEC document |
| August 10, 2026 Filed Aug 13, 2026 01:54 UTC |
Farajallah Awny Samaan BotrosChief Medical Officer
|
SaleAmerican Depositary Shares | 14,006 | $17.10 | $239,502.60 |
DisclosureSEC source: 0001493152-26-037515 · ownership.xml · nonDerivative · entry 1 Farajallah Awny Samaan Botros · CIK 0002121389 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,177 F1 · kind: Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 10, 2026 Filed Aug 13, 2026 01:53 UTC |
Ibrahim Ramy Riad AhmedPresident, PDT BU
|
SaleAmerican Depositary Shares | 7,277 | $17.10 | $124,436.70 |
DisclosureSEC source: 0001493152-26-037514 · ownership.xml · nonDerivative · entry 1 Ibrahim Ramy Riad Ahmed · CIK 0002121395 · President, PDT BU 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,588 F1 · kind: Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 10, 2026 Filed Aug 13, 2026 01:53 UTC |
Pacheco Rhonda JanicePresident, U.S. Business Unit
|
SaleAmerican Depositary Shares | 16,901 | $17.10 | $289,007.10 |
DisclosureSEC source: 0001493152-26-037513 · ownership.xml · nonDerivative · entry 1 Pacheco Rhonda Janice · CIK 0002111489 · President, U.S. Business Unit 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,507 F1 · kind: Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 10, 2026 Filed Aug 13, 2026 01:51 UTC |
Duprey Lauren RusckowskiChief Transformation Officer
|
SaleAmerican Depositary Shares | 47,586 | $17.10 | $813,720.60 |
DisclosureSEC source: 0001493152-26-037509 · ownership.xml · nonDerivative · entry 1 Duprey Lauren Rusckowski · CIK 0001977746 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,057 F1 · kind: Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 10, 2026 Filed Aug 13, 2026 01:50 UTC |
Plump Andrew StewartDirector · President, R&D
|
SaleAmerican Depositary Shares | 165,393 | $17.10 | $2,828,220.30 |
DisclosureSEC source: 0001493152-26-037507 · ownership.xml · nonDerivative · entry 1 Plump Andrew Stewart · CIK 0001977689 · Director · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 766,569 F1 · kind: Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 10, 2026 Filed Aug 13, 2026 01:46 UTC |
Pignagnoli Agosti MarcelloHead, Strat. & Port. Dev
|
SaleAmerican Depositary Shares | 22,957 | $17.10 | $392,564.70 |
DisclosureSEC source: 0001493152-26-037505 · ownership.xml · nonDerivative · entry 1 Pignagnoli Agosti Marcello · CIK 0001977817 · Head, Strat. & Port. Dev 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,977 F1 · kind: Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 10, 2026 Filed Aug 13, 2026 01:45 UTC |
Bitetti Teresa MariePresident, OBU
|
SaleAmerican Depositary Shares | 50,012 | $17.10 | $855,205.20 |
DisclosureSEC source: 0001493152-26-037502 · ownership.xml · nonDerivative · entry 1 Bitetti Teresa Marie · CIK 0001977608 · President, OBU 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,010 F1 · kind: Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 10, 2026 Filed Aug 13, 2026 01:39 UTC |
Ricci GabrieleChief Data & Tech. Officer
|
SaleAmerican Depositary Shares | 25,088 | $17.10 | $429,004.80 |
DisclosureSEC source: 0001493152-26-037494 · ownership.xml · nonDerivative · entry 1 Ricci Gabriele · CIK 0001977815 · Chief Data & Tech. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,654 F1 · kind: Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 10, 2026 Filed Aug 13, 2026 01:28 UTC |
Greenway Nicola Deidre PetalChief Human Resources Officer
|
SaleAmerican Depositary Shares | 6,774 | $17.10 | $115,835.40 |
DisclosureSEC source: 0001493152-26-037486 · ownership.xml · nonDerivative · entry 1 Greenway Nicola Deidre Petal · CIK 0002123546 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,029 F1 · kind: Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: The total in Column 5 represents the amount of American Depositary Shares held by the Reporting Person as of the date of this filing. Read SEC document |
| August 10, 2026 Filed Aug 13, 2026 01:27 UTC |
Kim Julie So-YoungDirector · President and CEO
|
SaleAmerican Depositary Shares | 89,090 | $17.10 | $1,523,439.00 |
DisclosureSEC source: 0001493152-26-037484 · ownership.xml · nonDerivative · entry 1 Kim Julie So-Young · CIK 0001977732 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 391,489 F1 · kind: Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 10, 2026 Filed Aug 13, 2026 01:25 UTC |
Platford Giles RichardPresident, IBU
|
SaleAmerican Depositary Shares | 31,083 | $17.10 | $531,519.30 |
DisclosureSEC source: 0001493152-26-037482 · ownership.xml · nonDerivative · entry 1 Platford Giles Richard · CIK 0001977620 · President, IBU 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,838 F1 · kind: Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 10, 2026 Filed Aug 13, 2026 01:23 UTC |
Furney Natalie Anne MarieGlobal General Counsel
|
SaleAmerican Depositary Shares | 30,868 | $17.10 | $527,842.80 |
DisclosureSEC source: 0001493152-26-037480 · ownership.xml · nonDerivative · entry 1 Furney Natalie Anne Marie · CIK 0002111535 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,298 F1 · kind: Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 20:10 UTC |
Greenway Nicola Deidre PetalChief Human Resources Officer
|
SaleAmerican Depositary Shares | 33,628 | $17.51 | $588,715.31 |
DisclosureSEC source: 0001493152-26-037351 · ownership.xml · nonDerivative · entry 2 Greenway Nicola Deidre Petal · CIK 0002123546 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,803 Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 20:10 UTC |
Greenway Nicola Deidre PetalChief Human Resources Officer
|
SaleAmerican Depositary Shares | 975 | $17.50 | $17,062.50 |
DisclosureSEC source: 0001493152-26-037351 · ownership.xml · nonDerivative · entry 1 Greenway Nicola Deidre Petal · CIK 0002123546 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,431 Read SEC document |
| July 10, 2026 Filed Jul 6, 2026 22:28 UTC |
MARAGANORE JOHNDirector
|
Disposition to issuerTax Obligation Award · Derivative | 1,152 | $4,931.20 | $5,680,742.40 |
DisclosureSEC source: 0001395064-26-000275 · wk-form4_1783376919.xml · derivative · entry 3 MARAGANORE JOHN · CIK 0001180432 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,152 shares Expires 2026-06-01 F3 · derivative.exercise_price: Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10. F3 · date: Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10. F4 · price: The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,883 to JPY 5,045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 10, 2026 Filed Jul 6, 2026 22:29 UTC |
GILLIS STEVENDirector
|
Disposition to issuerTax Obligation Award · Derivative | 1,152 | $4,931.20 | $5,680,742.40 |
DisclosureSEC source: 0001395064-26-000276 · wk-form4_1783376940.xml · derivative · entry 3 GILLIS STEVEN · CIK 0001229592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,152 shares Expires 2026-06-01 F3 · derivative.exercise_price: Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10. F3 · date: Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10. F4 · price: The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,883 to JPY 5,045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 10, 2026 Filed Jul 6, 2026 22:28 UTC |
Reed Kimberly A.Director
|
Disposition to issuerTax Obligation Award · Derivative | 1,152 | $4,931.20 | $5,680,742.40 |
DisclosureSEC source: 0001395064-26-000274 · wk-form4_1783376900.xml · derivative · entry 3 Reed Kimberly A. · CIK 0001873931 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,152 shares Expires 2026-06-01 F3 · derivative.exercise_price: Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10. F3 · date: Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10. F4 · price: The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,883 to JPY 5,045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 10, 2026 Filed Jul 6, 2026 22:14 UTC |
Iijima MasamiDirector
|
Disposition to issuerTax Obligation Award · Derivative | 2,152 | $4,931.20 | $10,611,942.40 |
DisclosureSEC source: 0001395064-26-000270 · wk-form4_1783376039.xml · derivative · entry 2 Iijima Masami · CIK 0002114485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,152 shares Expires 2026-06-01 F2 · derivative.exercise_price: Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10. F2 · date: Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10. F3 · price: The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,883 to JPY 5,045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 10, 2026 Filed Jul 6, 2026 22:10 UTC |
Tsusaka MikiDirector
|
Disposition to issuerTax Obligation Award · Derivative | 2,152 | $4,931.20 | $10,611,942.40 |
DisclosureSEC source: 0001395064-26-000263 · wk-form4_1783375803.xml · derivative · entry 2 Tsusaka Miki · CIK 0002113695 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,152 shares Expires 2026-06-01 F2 · derivative.exercise_price: Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10. F2 · date: Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10. F3 · price: The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,883 to JPY 5,045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 10, 2026 Filed Jul 6, 2026 22:09 UTC |
Miyabashira AsukaPresident, Japan Pharma B.U.
|
Disposition to issuerTax Obligation Award · Derivative | 1,022 | $4,931.40 | $5,039,890.80 |
DisclosureSEC source: 0001395064-26-000261 · wk-form4_1783375765.xml · derivative · entry 2 Miyabashira Asuka · CIK 0002111457 · President, Japan Pharma B.U. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,022 shares Expires 2026-06-01 F2 · derivative.exercise_price: Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10. F2 · date: Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10. F3 · price: The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,882 to JPY 5,050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 10, 2026 Filed Jul 6, 2026 22:09 UTC |
Furuta MilanoDirector · Chief Financial Officer
|
Disposition to issuerTax Obligation Award · Derivative | 16,619 | $4,931.50 | $81,956,598.50 |
DisclosureSEC source: 0001395064-26-000260 · wk-form4_1783375740.xml · derivative · entry 2 Furuta Milano · CIK 0002111400 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 16,619 shares Expires 2026-06-01 F2 · derivative.exercise_price: Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10. F2 · date: Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10. F3 · price: The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,882 to JPY 5,050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:03 UTC |
Shannon Elaine MaryPres., Global Supply & Quality
|
GrantAmerican Depositary Shares | 30,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000249 · wk-form4_1783375422.xml · nonDerivative · entry 1 Shannon Elaine Mary · CIK 0002009368 · Pres., Global Supply & Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,674 F1 · kind: Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:28 UTC |
MARAGANORE JOHNDirector
|
GrantTax Obligation Award · Derivative | 1,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000275 · wk-form4_1783376919.xml · derivative · entry 4 MARAGANORE JOHN · CIK 0001180432 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,319 Underlying: Ordinary Shares · 1,319 shares Expires 2029-06-01 F5 · derivative.exercise_price: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:28 UTC |
MARAGANORE JOHNDirector
|
GrantOrdinary Shares | 3,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000275 · wk-form4_1783376919.xml · nonDerivative · entry 1 MARAGANORE JOHN · CIK 0001180432 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,400 F1 · kind: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029. F2 · balance_after: Reflects the conversion of 3,100 Ordinary Shares into 6,200 American Depositary Shares upon vesting of RSUs. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:29 UTC |
GILLIS STEVENDirector
|
GrantTax Obligation Award · Derivative | 1,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000276 · wk-form4_1783376940.xml · derivative · entry 4 GILLIS STEVEN · CIK 0001229592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,319 Underlying: Ordinary Shares · 1,319 shares Expires 2029-06-01 F5 · derivative.exercise_price: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:29 UTC |
GILLIS STEVENDirector
|
GrantOrdinary Shares | 3,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000276 · wk-form4_1783376940.xml · nonDerivative · entry 1 GILLIS STEVEN · CIK 0001229592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,400 F1 · kind: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029. F2 · balance_after: Reflects the conversion of 3,100 Ordinary Shares into 6,200 American Depositary Shares upon vesting of RSUs. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:12 UTC |
BROUSSARD BRUCE DDirector
|
GrantTax Obligation Award · Derivative | 1,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000268 · wk-form4_1783375918.xml · derivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,319 Underlying: Ordinary Shares · 1,319 shares Expires 2029-06-01 F2 · derivative.exercise_price: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:12 UTC |
BROUSSARD BRUCE DDirector
|
GrantAmerican Depositary Shares | 3,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000268 · wk-form4_1783375918.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,595 F1 · kind: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:28 UTC |
Reed Kimberly A.Director
|
GrantTax Obligation Award · Derivative | 1,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000274 · wk-form4_1783376900.xml · derivative · entry 4 Reed Kimberly A. · CIK 0001873931 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,319 Underlying: Ordinary Shares · 1,319 shares Expires 2029-06-01 F5 · derivative.exercise_price: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:28 UTC |
Reed Kimberly A.Director
|
GrantOrdinary Shares | 3,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000274 · wk-form4_1783376900.xml · nonDerivative · entry 1 Reed Kimberly A. · CIK 0001873931 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,400 F1 · kind: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029. F2 · balance_after: Reflects the conversion of 3,100 Ordinary Shares into 6,200 American Depositary Shares upon vesting of RSUs. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:14 UTC |
Iijima MasamiDirector
|
GrantTax Obligation Award · Derivative | 1,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000270 · wk-form4_1783376039.xml · derivative · entry 3 Iijima Masami · CIK 0002114485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,937 Underlying: Ordinary Shares · 1,937 shares Expires 2029-06-01 F4 · derivative.exercise_price: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:14 UTC |
Iijima MasamiDirector
|
GrantOrdinary Shares | 1,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000270 · wk-form4_1783376039.xml · nonDerivative · entry 1 Iijima Masami · CIK 0002114485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,601 F1 · kind: Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 1, 2029. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:11 UTC |
Stoffels PaulusDirector
|
GrantTax Obligation Award · Derivative | 1,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000266 · wk-form4_1783375873.xml · derivative · entry 2 Stoffels Paulus · CIK 0001559387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,307 Underlying: Ordinary Shares · 1,307 shares Expires 2029-06-01 F2 · derivative.exercise_price: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:11 UTC |
Stoffels PaulusDirector
|
GrantOrdinary Shares | 3,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000266 · wk-form4_1783375873.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,800 F1 · kind: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:10 UTC |
Kimura KoichiroDirector
|
GrantTax Obligation Award · Derivative | 1,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000264 · wk-form4_1783375832.xml · derivative · entry 2 Kimura Koichiro · CIK 0002137620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,937 Underlying: Ordinary Shares · 1,937 shares Expires 2029-06-01 F2 · derivative.exercise_price: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:10 UTC |
Kimura KoichiroDirector
|
GrantOrdinary Shares | 1,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000264 · wk-form4_1783375832.xml · nonDerivative · entry 1 Kimura Koichiro · CIK 0002137620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800 F1 · kind: Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 1, 2029. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:10 UTC |
Tsusaka MikiDirector
|
GrantTax Obligation Award · Derivative | 1,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000263 · wk-form4_1783375803.xml · derivative · entry 3 Tsusaka Miki · CIK 0002113695 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,937 Underlying: Ordinary Shares · 1,937 shares Expires 2029-06-01 F4 · derivative.exercise_price: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:10 UTC |
Tsusaka MikiDirector
|
GrantOrdinary Shares | 1,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000263 · wk-form4_1783375803.xml · nonDerivative · entry 1 Tsusaka Miki · CIK 0002113695 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,200 F1 · kind: Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 1, 2029. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:09 UTC |
Miyabashira AsukaPresident, Japan Pharma B.U.
|
GrantTax Obligation Award · Derivative | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000261 · wk-form4_1783375765.xml · derivative · entry 5 Miyabashira Asuka · CIK 0002111457 · President, Japan Pharma B.U. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 666 Underlying: Ordinary Shares · 666 shares Expires 2029-06-01 F4 · derivative.exercise_price: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:09 UTC |
Miyabashira AsukaPresident, Japan Pharma B.U.
|
GrantTax Obligation Award · Derivative | 664 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000261 · wk-form4_1783375765.xml · derivative · entry 4 Miyabashira Asuka · CIK 0002111457 · President, Japan Pharma B.U. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,174 Underlying: Ordinary Shares · 664 shares Expires 2028-06-01 F4 · derivative.exercise_price: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:09 UTC |
Miyabashira AsukaPresident, Japan Pharma B.U.
|
GrantTax Obligation Award · Derivative | 664 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000261 · wk-form4_1783375765.xml · derivative · entry 3 Miyabashira Asuka · CIK 0002111457 · President, Japan Pharma B.U. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,392 Underlying: Ordinary Shares · 664 shares Expires 2027-06-01 F4 · derivative.exercise_price: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:09 UTC |
Miyabashira AsukaPresident, Japan Pharma B.U.
|
GrantOrdinary Shares | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000261 · wk-form4_1783375765.xml · nonDerivative · entry 1 Miyabashira Asuka · CIK 0002111457 · President, Japan Pharma B.U. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,500 F1 · kind: Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest in three equal annual installments beginning on June 1, 2027. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:09 UTC |
Furuta MilanoDirector · Chief Financial Officer
|
GrantTax Obligation Award · Derivative | 4,288 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000260 · wk-form4_1783375740.xml · derivative · entry 5 Furuta Milano · CIK 0002111400 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,288 Underlying: Ordinary Shares · 4,288 shares Expires 2029-06-01 F4 · derivative.exercise_price: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:09 UTC |
Furuta MilanoDirector · Chief Financial Officer
|
GrantTax Obligation Award · Derivative | 4,288 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000260 · wk-form4_1783375740.xml · derivative · entry 4 Furuta Milano · CIK 0002111400 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,482 Underlying: Ordinary Shares · 4,288 shares Expires 2028-06-01 F4 · derivative.exercise_price: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.